Company Filing History:
1 out of 1,373 
1 out of 1,036 
Years Active: 2022
Title: Rob Sellar: Innovator in Hematology
Introduction
Rob Sellar is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of hematology, particularly in the treatment of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Philadelphia-negative myeloproliferative neoplasms (MPN). His innovative work has the potential to impact many lives.
Latest Patents
Rob Sellar holds a patent titled "Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs)." This patent describes methods for treating subjects with CHIP or MPN, such as polycythemia vera (PV) or essential thrombocythemia (ET), using inhibitors of JAK-STAT signaling. He has 1 patent to his name.
Career Highlights
Throughout his career, Rob has worked with prestigious institutions, including Brigham and Women's Hospital and Children's Medical Center Corporation. His work in these organizations has allowed him to advance his research and contribute to the medical community.
Collaborations
Rob has collaborated with esteemed colleagues, including Benjamin L. Ebert and Ofir Wolach. These partnerships have enriched his research and fostered innovation in his field.
Conclusion
Rob Sellar's contributions to hematology through his patent and collaborations highlight his role as an innovator in medical research. His work continues to pave the way for advancements in treatment options for patients with hematological conditions.